Mei, Davide Antonio
 Distribuzione geografica
Continente #
AS - Asia 3.410
NA - Nord America 2.474
EU - Europa 1.487
SA - Sud America 476
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 62
OC - Oceania 9
Totale 8.002
Nazione #
US - Stati Uniti d'America 2.353
SG - Singapore 1.117
CN - Cina 987
IT - Italia 708
VN - Vietnam 359
BR - Brasile 342
HK - Hong Kong 293
BD - Bangladesh 194
KR - Corea 164
FI - Finlandia 160
GB - Regno Unito 128
DE - Germania 107
RU - Federazione Russa 97
FR - Francia 79
AR - Argentina 57
CA - Canada 55
ID - Indonesia 54
NL - Olanda 47
IN - India 38
MX - Messico 34
SE - Svezia 26
TR - Turchia 23
ES - Italia 22
PL - Polonia 21
UZ - Uzbekistan 19
CO - Colombia 18
AT - Austria 17
JP - Giappone 17
PK - Pakistan 17
EC - Ecuador 16
IQ - Iraq 16
AE - Emirati Arabi Uniti 15
ZA - Sudafrica 15
CL - Cile 14
TW - Taiwan 14
UA - Ucraina 14
LT - Lituania 12
SA - Arabia Saudita 12
EG - Egitto 10
VE - Venezuela 10
BE - Belgio 9
MA - Marocco 9
TH - Thailandia 9
AU - Australia 8
AZ - Azerbaigian 7
KE - Kenya 7
TN - Tunisia 7
GE - Georgia 6
KZ - Kazakistan 6
BO - Bolivia 5
CU - Cuba 5
DZ - Algeria 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PT - Portogallo 5
PY - Paraguay 5
SV - El Salvador 5
BG - Bulgaria 4
CR - Costa Rica 4
IE - Irlanda 4
MY - Malesia 4
PH - Filippine 4
RO - Romania 4
UY - Uruguay 4
AM - Armenia 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
HU - Ungheria 3
NP - Nepal 3
RS - Serbia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CY - Cipro 2
KG - Kirghizistan 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 7.906
Città #
Singapore 701
Hefei 500
Santa Clara 361
Ashburn 360
San Jose 348
Hong Kong 290
Seoul 164
Beijing 128
Ho Chi Minh City 119
Council Bluffs 115
Helsinki 110
Los Angeles 93
Hanoi 87
New York 82
London 80
Milan 68
The Dalles 63
Chicago 59
Bologna 58
Buffalo 53
Rome 49
Lauterbourg 46
Munich 42
Dallas 40
São Paulo 37
Jakarta 36
Lappeenranta 36
Modena 31
Kent 29
Moscow 29
Boardman 28
Shanghai 26
Salt Lake City 25
Frankfurt am Main 23
Orem 23
Mexico City 21
Amsterdam 18
Da Nang 17
Tashkent 17
Haiphong 16
Naples 16
Montreal 15
Portsmouth 15
Nuremberg 14
Warsaw 14
Chandler 13
Nyköping 13
Tokyo 13
Turin 13
Turku 13
Fairfield 12
Curitiba 11
Houston 11
Rio de Janeiro 11
Chennai 10
Düsseldorf 10
Paris 10
Santiago 10
Stockholm 10
Tampa 10
Toronto 10
Atlanta 9
Hangzhou 9
Istanbul 9
Miami 9
Phoenix 9
Salvador 9
Seattle 9
Bari 8
Brescia 8
Campinas 8
Elk Grove Village 8
Manchester 8
Newark 8
Perugia 8
Vienna 8
Biên Hòa 7
Brooklyn 7
Brussels 7
Calgary 7
Carpi 7
Catania 7
Columbus 7
Florence 7
Fortaleza 7
Hillsboro 7
Hải Dương 7
Mumbai 7
North Bergen 7
Palermo 7
Parma 7
Redondo Beach 7
Reggio Emilia 7
Bắc Ninh 6
Dhaka 6
Ferrara 6
Ha Long 6
Madrid 6
Nairobi 6
Quito 6
Totale 4.970
Nome #
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 280
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 264
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 257
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 251
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 224
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 221
Remote monitoring and telemedicine in heart failure: implementation and benefits 220
Single-lead VDD pacing: a literature review on short-term and long-term performance 201
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 199
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 189
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 176
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 171
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 169
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 167
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 164
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 158
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 158
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 156
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 156
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 156
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 154
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 153
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: An analysis from the GLORIA-AF registry 147
Clinical decisions for appropriate management of patients with atrial fibrillation 146
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 144
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 139
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry 136
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 129
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 124
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 123
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry 120
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 119
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 117
Antiarrhythmic drugs in the era of atrial fibrillation ablation 115
Prepare our healthcare systems to manage complexity: the case of atrial fibrillation 111
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 107
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 106
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 103
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 98
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry 92
Atrial fibrillation screening: The importance of the patient perspective 91
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III 88
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 85
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial 82
Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry 79
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 78
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 75
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 74
A European-Multicenter Network for the Implementation of Artificial Intelligence to Manage Complexity and Comorbidities of Atrial Fibrillation Patients: The ARISTOTELES Consortium 67
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making? 63
Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future? 63
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort 61
Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post‐hoc analysis from the WARCEF trial 59
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry 54
Female sex as risk factor for undertreatment: need for a paradigm shift in the care of atrial fibrillation and ischaemic disease 53
Antiarrhythmic drugs and ablation in patients with atrial fibrillation: New perspectives 48
Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time? 48
Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey? 47
Multimorbidity, frailty and polypharmacy in European and Asian patients with atrial fibrillation: a comparison of two regional prospective observational registries 47
Atrial fibrillation ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term 46
Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project 43
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation 43
From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients 29
The intriguing relationships between atrial fibrillation and heart failure: insights from cardiac implantable electronic devices 28
Mineralocorticoids and outcome improvement in heart failure patients with and without atrial fibrillation: a systematic review and a meta-analysis 21
Application of Artificial Intelligence in the Early Detection and Management of Atrial Fibrillation: State-of-the-art Review 16
A multistate model of clinical trajectories of heart failure patients with implantable electronic devices followed with remote monitoring: What outcome implications of alerts at long term follow up? 16
Detection of left ventricular hypertrophy through ECG: diagnostic performance and comparison of ten ECG scores in different hypertrophic conditions 16
Evolution in the approach to atrial fibrillation: from screening for asymptomatic episodes to implementing artificial intelligence for refined risk prediction 10
Impact of cardiovascular-kidney-metabolic conditions on clinical outcomes in patients with atrial fibrillation: results from a prospective cohort 10
Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries 8
Intensification of monitoring for improving detection of atrial fibrillation after a presumed "trigger- induced episode" due to potentially reversible factors: what tools and what implications for decision making? 8
Renal function in patients with atrial fibrillation: From Virchow's triad to real-world practice 7
In patients with chronic coronary syndrome and high atherothrombotic risk, adding aspirin to OAC increased adverse CV events at 2 y 7
Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA-AF Registry Phase III 7
Impact of Left Bundle Branch Pacing on Left Ventricular Mechanical Efficiency 5
Totale 8.002
Categoria #
all - tutte 33.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 2 1 0 2 6 0 0 1 3 6 10
2022/2023110 7 6 8 7 5 5 4 12 15 6 27 8
2023/2024427 5 18 26 52 109 47 39 44 9 15 20 43
2024/20251.783 24 12 17 76 205 282 168 139 186 131 292 251
2025/20265.333 342 233 378 662 600 233 693 306 629 490 393 374
2026/2027305 280 25 0 0 0 0 0 0 0 0 0 0
Totale 8.002